Anthony Chalmers is Chair of Clinical Oncology at the University of Glasgow. His clinical practice at the Beatson West of Scotland Cancer Centre is devoted to the treatment of patients with brain tumours, and he runs the Translational Radiation Biology laboratory in the Institute for Cancer Sciences. His main research interest is in improving outcomes for patients with glioblastoma by combining radiotherapy with targeted drug therapy, but his research interest in radiotherapy-drug combinations extend across tumour sites. He is Deputy Chair of the NCRI Clinical and Translational Radiotherapy Research Working Group (CTRad) and leads the CTRad Radiotherapy-Drug Combinations Consortium. He is also vice-chair of the CRUK Clinical Trials Awards and Advisory Committee (CTAAC) and is on the Scientific Committees of the European Association for Neuro-Oncology (EANO) and the European Society for Therapeutic Radiation Oncology (ESTRO).